Recently Viewed

News Announcement

Lasa Supergenerics: Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended June 30 2026

14-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Lasa Supergenerics

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 06.15 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended June 30 2026.2. Limited Review Report from Statutory Auditor for the quarter ended on June 30 2026.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan